Literature DB >> 10574904

The scale of heart failure: diagnosis and management issues for primary care.

F D Hobbs1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10574904      PMCID： PMC1766518          DOI： 10.1136/hrt.82.2008.iv8

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  6 in total

1.  Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population.

Authors:  T A McDonagh; C E Morrison; A Lawrence; I Ford; H Tunstall-Pedoe; J J McMurray; H J Dargie
Journal:  Lancet       Date:  1997-09-20       Impact factor: 79.321

2.  Why are angiotensin converting enzyme inhibitors underutilised in the treatment of heart failure by general practitioners?

Authors:  A R Houghton; A J Cowley
Journal:  Int J Cardiol       Date:  1997-03       Impact factor: 4.164

3.  Validity of clinical diagnosis of heart failure in primary health care.

Authors:  J Remes; H Miettinen; A Reunanen; K Pyörälä
Journal:  Eur Heart J       Date:  1991-03       Impact factor: 29.983

4.  Re-used pacemakers--as safe as new? A retrospective case-control study.

Authors:  C L Linde; A Bocray; H Jonsson; M Rosenqvist; K Rådegran; L Rydén
Journal:  Eur Heart J       Date:  1998-01       Impact factor: 29.983

5.  Trends in hospitalization for heart failure in Scotland 1980-1990.

Authors:  J McMurray; T McDonagh; C E Morrison; H J Dargie
Journal:  Eur Heart J       Date:  1993-09       Impact factor: 29.983

6.  Echocardiography in chronic heart failure in the community.

Authors:  N M Wheeldon; T M MacDonald; C J Flucker; A D McKendrick; D G McDevitt; A D Struthers
Journal:  Q J Med       Date:  1993-01
  6 in total
  5 in total

1.  Pharmaceutical care of patients with heart failure.

Authors:  A Sadik; M Yousif; J C McElnay
Journal:  Br J Clin Pharmacol       Date:  2005-08       Impact factor: 4.335

2.  Association of increased parathyroid hormone with neuroendocrine activation and endothelial dysfunction in elderly men with heart failure.

Authors:  G Loncar; B Bozic; S Dimkovic; N Prodanovic; Z Radojicic; V Cvorovic; B Putnikovic; V Popovic
Journal:  J Endocrinol Invest       Date:  2010-09-02       Impact factor: 4.256

3.  Cost effectiveness of bisoprolol in the treatment of chronic congestive heart failure in Sweden: analysis using data from the Cardiac Insufficiency Bisoprolol Study II trial.

Authors:  M Ekman; N Zethraeus; B Jönsson
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 4.  The use of positive inotropes in end-of-life heart failure care.

Authors:  Deirdre J Nauman; Ray E Hershberger
Journal:  Curr Heart Fail Rep       Date:  2007-09

Review 5.  Vitamin D insufficiency in congestive heart failure: why and what to do about it?

Authors:  Armin Zittermann; Stefanie S Schleithoff; Reiner Koerfer
Journal:  Heart Fail Rev       Date:  2006-03       Impact factor: 4.654
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.